D. Teta

Discipline

Education (3) Sociologie (1) Psychologie (1)

Type de document

Articles (23) Recensions (4)

Type de document

Autres (1)

Co-auteur

Auteur

Date

Source

Source

Mot-clé

Patients (13) Patients (13) Treatment (12) Human beings (11) risque (8) dialyse (8) Risk (8) Dialysis (8) plasma (8) maladie (8) thérapie (7) maladie (7) âge (7) Methods (7) Therapeutics (7) Chronic renal failure (7) Older people (7) Age (7) Methods (7) Age (7) Control (6) Population (6) Population (6) analyse (5) énergie (5) effet (5) adulte (5) Serum (5) Power resources (5) Power (Mechanics) (5)

Mot-clé

Resonance ionization spectroscopy (1) Medicine, Preventive (1) Processing (1) Medicina preventiva (1) Maladie thromboembolique veineuse (1) Spectroscopie d'ionisation résonante (1) Transformation (1) Médecine préventive (1) prophylaxie (1)

Documents écrit par D. Teta (23) | parle de D. Teta (1)

Glycine increases fat-free mass in malnourished haemodialysis patients: a randomized double-blind crossover trial.
L. Genton et al.
Eculizumab as a New Treatment for Severe Acute Post-infectious Glomerulonephritis: Two Case Reports.
H. Chehade et al. (31 juil. 2021)
Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
G. Guzzo et al. (6 juil. 2021)
Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.
G. Guzzo et al. (2021)
The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies.
C. Bernuy-Guevara et al. (16 sept. 2020)
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
N.A. Dhayat et al. (10 déc. 2018)
Changing trends in end-stage renal disease patients with diabetes.
Y. Lu et al. (11 juil. 2017)
Erratum to: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.
S. Kissling et al. (9 mars 2017)
A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.
S. Kissling et al. (1 mars 2017)
Prevalence and Diagnostic Approach to Sleep Apnea in Hemodialysis Patients: A Population Study.
V. Forni Ogna et al. (2015)
Extraskeletal Functions of Vitamin D.
D. Santoro et al. (2015)
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system.
D. Santoro et al. (2015)
Vitamin D: a review on its effects on muscle strength, the risk of fall, and frailty.
M. Halfon et al. (2015)
Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group.
N.E. Deutz et al.
Pioglitazone improves fat distribution, the adipokine profile and hepatic insulin sensitivity in non-diabetic end-stage renal disease subjects on maintenance dialysis: a randomized cross-over pilot study.
A. Zanchi et al.
Physical activity and energy expenditure in haemodialysis patients: an international survey.
C.M. Avesani et al. (2012)
Incidence, complications and risk factors for severe falls in patients on maintenance haemodialysis.
A. Rossier et al. (2012)
Haemodialysis acutely reduces the plasma levels of ADMA without reversing impaired NO-dependent vasodilation.
R.P. Engelberger et al. (2009)
Optimal and continuous anaemia control in a cohort of dialysis patients in Switzerland.
C.M. Mathieu et al. (2008)
Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life.
D. Fouque et al. (2008)
The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes
D. Teta et al.
Glucose-containing peritoneal dialysis fluids regulate leptin secretion from 3T3-L1 adipocytes
D. Teta et al.
Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients.
D. Teta et al. (2005)

Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
vaudois Centre hospitalier universitaire et al.